Avaleht › Difuusne suure B-raku lümfoom › Oregon › Portland
Difuusne suure B-raku lümfoom kliinilised uuringud linnas Portland, OR
15 uuringut haiguse Difuusne suure B-raku lümfoom jaoks otsivad osalejaid linnas Portland ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
VärbamineFaas 2
- Oregon Health and Science University, Portland
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
VärbamineFaas 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
VärbamineFaas 3
- Kaiser Permanente Interstate Medical Office - Central ( Site 0181), Portland
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
VärbamineFaas 2
- Providence Portland Medical Center ( Site 0120), Portland
- Providence Oncology and Hematology Clinic Westside ( Site 0179), Portland
Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
VärbamineVaatlusuuring
- OHSU Knight Cancer Institute, Portland
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
VärbamineFaas 1
- Oregon Health & Science University (OHSU), Portland
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
VärbamineFaas 1/2
- Oregon Health and Science University ( Site 1004), Portland
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
VärbamineFaas 2
- Providence Portland Medical Center, Portland
- Providence St. Vincent Medical Center, Portland
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
VärbamineFaas 1/2
- Oregon Health & Science University, Portland
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
VärbamineVaatlusuuring
- Oregon Health and Science University Knight Cancer Institute, Portland
DALY II USA/ MB-CART2019.1 for DLBCL
VärbamineFaas 2
- Oregon Health and Science University Knight Cancer Institute, Portland
Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma
VärbamineFaas 1/2
- OHSU Knight Cancer Institute, Portland
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
VärbamineFaas 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- ja veel 1
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
VärbamineFaas 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · 12 mi kaugusel
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
VärbamineFaas 1
- Oregon Health & Science University, Portland
Difuusne suure B-raku lümfoom uuringud teistes linnades
- New York City, NY21 uuringut
- Baldwin Park, CA19 uuringut
- Chicago, IL18 uuringut
- Houston, TX17 uuringut
- Los Angeles, CA17 uuringut
- Boston, MA16 uuringut
- Milwaukee, WI16 uuringut
- Nashville, TN15 uuringut
- Philadelphia, PA15 uuringut
- Durham, NC14 uuringut
- Dallas, TX13 uuringut
- Seattle, WA12 uuringut
Muud uuringud linnas Portland
- Mitteväikerakuline kopsuvähk46 uuringut
- Vähk (kõik liigid)34 uuringut
- Eesnäärmevähk33 uuringut
- Rinnavähk33 uuringut
- Metastaatiline vähk29 uuringut
- Käär- ja pärasoolevähk28 uuringut
- Munasarjavähk27 uuringut
- Kopsuvähk26 uuringut
- Äge müeloidne leukeemia25 uuringut
- Endomeetriumivähk24 uuringut
- Pea ja kaela lameepiteeli kartsinoom19 uuringut
- Pankreasevähk19 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.